Patient preferences and perceptions of inflammatory bowel disease monitoring tools: a cross-sectional survey from a specialized gastroenterology clinic in Panama
DOI:
https://doi.org/10.47892/rgp.2026.463.2188Palabras clave:
Ultrasonography, Inflammatory Bowel Disease, Patient Acceptance of Health Care, Patient EducationResumen
Objectives: The aim of this study was to evaluate patient preferences and perceptions regarding commonly used tools for monitoring inflammatory bowel disease (IBD), including colonoscopy, intestinal ultrasound (IUS), computed tomography or magnetic resonance imaging (CT/MRI), and fecal calprotectin (FC). Materials and methods: A cross-sectional anonymous electronic survey was administered to adult patients with a confirmed diagnosis of IBD attending a specialized private gastroenterology clinic in Panama. Eighty-two patients were invited to participate, and fifty-one completed the survey. Intestinal ultrasound was associated with the highest levels of satisfaction and acceptability. Results: Colonoscopy was most frequently perceived as providing physicians with the most useful clinical information and as the test that best helped patients understand their disease status. When asked which single test they would prefer to repeat for ongoing disease monitoring, most participants selected IUS. These findings suggest that patients favor non-invasive monitoring strategies, although colonoscopy continues to be perceived as the diagnostic reference standard. Conclusions: Improving patient education regarding the clinical value of IUS may facilitate broader adoption of patient-centered monitoring approaches in routine practice.
Descargas
Citas
Hashash JG, Limdi JK, Shapiro JM, Shah SA. Medical management of inflammatory bowel diseases. BMJ. 2025;391:e079050. doi: 10.1136/bmj-2025-079050.
Peyrin-Biroulet L, Sandborn W, Sands BE, Reinisch W, Bemelman W, Bryant RV, et al. Selecting Therapeutic Targets in Inflammatory Bowel Disease (STRIDE): Determining Therapeutic Goals for Treat-to-Target. Am J Gastroenterol. 2015;110(9):1324-38. doi: 10.1038/ajg.2015.233.
Turner D, Ricciuto A, Lewis A, D’Amico F, Dhaliwal J, Griffiths AM, et al. STRIDE-II: An Update on the Selecting Therapeutic Targets in Inflammatory Bowel Disease (STRIDE) Initiative of the International Organization for the Study of IBD (IOIBD): Determining Therapeutic Goals for Treat-to-Target strategies in IBD. Gastroenterology. 2021;160(5):1570-1583. doi: 10.1053/j.gastro.2020.12.031.
American Society for Gastrointestinal Endoscopy Standards of Practice Committee; Shergill AK, Lightdale JR, Bruining DH, Acosta RD, Chandrasekhara V, et al. The role of endoscopy in inflammatory bowel disease. Gastrointest Endosc. 2015;81(5):1101-21.e1-13. doi: 10.1016/j.gie.2014.10.030.
Dekker E, Nass KJ, Iacucci M, Murino A, Sabino J, Bugajski M, et al. Performance measures for colonoscopy in inflammatory bowel disease patients: European Society of Gastrointestinal Endoscopy (ESGE) Quality Improvement Initiative. Endoscopy. 2022;54(9):904-915. doi: 10.1055/a-1874-0946.
Kucharzik T, Taylor S, Allocca M, Burisch J, Ellul P, Iacucci M, et al. ECCO-ESGAR-ESP-IBUS Guideline on Diagnostics and Monitoring of Patients with Inflammatory Bowel Disease: Part 1. J Crohns Colitis. 2025;19(7):jjaf106. doi: 10.1093/ecco-jcc/jjaf106.
Yanai H, Feakins R, Allocca M, Burisch J, Ellul P, Iacucci M, et al. ECCO-ESGAR-ESP-IBUS Guideline on Diagnostics and Monitoring of Patients with Inflammatory Bowel Disease: Part 2. J Crohns Colitis. 2025;19(7):jjaf107. doi: 10.1093/ecco-jcc/ jjaf107.
Goodsall TM, Noy R, Nguyen TM, Costello SP, Jairath V, Bryant RV. Systematic Review: Patient Perceptions of Monitoring Tools in Inflammatory Bowel Disease. J Can Assoc Gastroenterol. 2020;4(2):e31-e41. doi: 10.1093/jcag/gwaa001.
Chavannes, M, Dolinger, M, Cohen-Mekelburg S, et al. Chavannes M, Dolinger MT, Cohen-Mekelburg S, Abraham B. AGA Clinical Practice Update on the Role of Intestinal Ultrasound in Inflammatory Bowel Disease: Commentary. Clin Gastroenterol Hepatol. 2024;22(9):1790-1795.e1. doi: 10.1016/j.cgh.2024.04.039.
Allocca M, Jairath V, Sands BE, Rubin DT, Caron B, Laurent V, et al. International consensus on the use of intestinal ultrasound in inflammatory bowel disease trials. J Crohns Colitis. 2025;19(9):jjaf170. doi: 10.1093/ecco-jcc/jjaf170.
Abraham BP, Reddy D, Saleh A. Integrating Intestinal Ultrasound into an Inflammatory Bowel Disease Practice: How to Get Started. Crohns Colitis 360. 2023;5(3):otad043. doi: 10.1093/crocol/otad043.
Gore E, Femino C, Aronskyy I, Miller A, Zelman SR, Winter MW, et al. The Patient Experience with Point-of-Care Intestinal Ultrasound for Inflammatory Bowel Disease Monitoring: A Multicenter Study. Dig Dis Sci. 2026;71(2):569-577. doi: 10.1007/s10620-025-09390-4.
van Wassenaer EA, van der Klift RR, Staphorst MS, van der Lee JH, Benninga MA, Koot BGP. The child’s perception on monitoring inflammatory bowel disease activity. Eur J Pediatr. 2022;181(3):1143-1149. doi: 10.1007/s00431-021- 04315-5.
Allocca M, Fiorino G, Bonifacio C, Furfaro F, Gilardi D, Argollo M, et al. Comparative Accuracy of Bowel Ultrasound Versus Magnetic Resonance Enterography in Combination With Colonoscopy in Assessing Crohn’s Disease and Guiding Clinical Decision-making. J Crohns Colitis. 2018;12(11):1280-1287. doi: 10.1093/ecco-jcc/jjy093.
Descargas
Publicado
Cómo citar
Número
Sección
Licencia
Derechos de autor 2026 Carlos Rettally, Valeria Orillac, Viviana Parra-Izquierdo, Keren Castro-Lopez, Kenneth Ernest-Suarez

Esta obra está bajo una licencia internacional Creative Commons Atribución 4.0.
Revista de Gastroenterología del Perú by Sociedad Peruana de Gastroenterología del Perú is licensed under a Licencia Creative Commons Atribución 4.0 Internacional..
Aquellos autores/as que tengan publicaciones con esta revista, aceptan los términos siguientes:
- Los autores/as conservarán sus derechos de autor y garantizarán a la revista el derecho de primera publicación de su obra, el cuál estará simultáneamente sujeto a la Licencia de reconocimiento de Creative Commons que permite a terceros compartir la obra siempre que se indique su autor y su primera publicación esta revista.
- Los autores/as podrán adoptar otros acuerdos de licencia no exclusiva de distribución de la versión de la obra publicada (p. ej.: depositarla en un archivo telemático institucional o publicarla en un volumen monográfico) siempre que se indique la publicación inicial en esta revista.
- Se permite y recomienda a los autores/as difundir su obra a través de Internet (p. ej.: en archivos telemáticos institucionales o en su página web) antes y durante el proceso de envío, lo cual puede producir intercambios interesantes y aumentar las citas de la obra publicada. (Véase El efecto del acceso abierto).













2022